Sandoz Group AG filed a draft anti-dumping complaint with the European Commission on May 28 regarding amoxicillin imports from China. The Switzerland-based drugmaker claims Chinese competitors use state subsidies and below-cost pricing to dominate the penicillin market. The move seeks to protect the only remaining vertically integrated production network for penicillins left in Europe.

Defending European Antibiotic Production